- You should have a Ph.D. in mass spectrometry and/or bioanalytical chemistry, with experience in small molecule mass spectrometry and biological sample preparation techniques. Prior experience in lipid analysis and bioinformatics is strongly preferred.
This blog provides news on the informatics side of metabolomics in Europe. It will list local and important international conferences, vacancies, and interesting publications.
Monday, February 4, 2008
Sweden is looking for metabolomics post-docs too
It seems that NL is not the only country in need of qualified metabolomics post-docs. This position in Stockholm (found via NatureJobs) requires a bench analytical chemist :
Labels:
location:SE,
metabolomics,
stockholm,
Sweden
Saturday, January 26, 2008
Post-doc and PhD vacancies in Netherlands Metabolomics Centre
A few new vacancies appeared on the Netherlands Metabolomics Centre website:
- The mission of NMC is to take the lead in the creation of a world-class metabolomics knowledge infrastructure to improve personal health. The NMC has recently been founded by a subsidy from the Netherlands Genomics Initiative, and will have a budget of 50 M€ for the period from 2008-2012. The researchers will have a high degree of collaboration with each other, and will conduct their research at different places.
- Post-doctoral Research Fellows
- PhD students
The NMC invites applications for the following positions:
Thursday, January 10, 2008
Chemical Systems Biology Meeting, Philidelphia, August 17-21, 2008
Rajarshi Guha wrote on the Chemical Computation List:
The CINF division of the American Chemical Society is oriented at chemical information (molecular really, so including metabolites) and includes chemoinformatics, and increasingly bioinformatics.
- Chemical Systems Biology: Integrating Chemistry and Biology for
Network Models
236th ACS National Meeting
Philadelphia, August 17-21, 2008
CINF Division
----------------------------------
Dear Colleagues,
Josef Scheiber and I are organizing a symposium focusing on the use of biological networks and their models for the purposes of drug discovery. Traditionally, such models have been applied to large scale biological systems such as protein-protein interaction networks. Recently, there has been increased interest in the study of these networks to gain a global understanding of biological systems and the impact of small molecules to them in the context of drug discovery. As a result, it has become important that such models integrate small molecules with the usual biological systems. By leveraging the power of established cheminformatics methods along with the network models we get closer to the goal of "chemical systems biology", the full integration of chemical and biological data in the development of better in silico-methods for drug discovery.
We invite you to submit contributions that address various computational aspects of this approach including, but not limited to: network construction, integration of multiple data sources in network models, drug repurposing, target identification, polypharmacology, incorporation of chemical structure/similarity into network models, bridging chemical structure and biological structure based network models. Case studies where computational network models have provided experimental insight are also welcome.
We would also like to point out that sponsorship opportunities are available.
Please use the on-line abstract submission system (OASYS) for submitting your abstract (http://oasys.acs.org/oasys.htm). OASYS will be accepting abstracts between 28th January and 24th March, 2008.
Please contact Josef or myself if you have any questions.
Thanks,
Josef Scheiber Rajarshi Guha
Novartis Indiana University
The CINF division of the American Chemical Society is oriented at chemical information (molecular really, so including metabolites) and includes chemoinformatics, and increasingly bioinformatics.
Labels:
bioinformatics,
chemoinformatics,
metabolites,
systems biology
Monday, December 3, 2007
Two vacancies with TI Pharma
TI Pharma has two metabolomics related PhD vacancies:
- Integrative Metabolic Production and Profiling as a Novel Strategy in Hit-to-Lead Selection
In modern drug discovery innovative, efficient and throughput-directed metabolic stability assessment and metabolic profiling, i.e. metabolite identification and active metabolite screening, is becoming of key-importance. In this TI Pharma project, a new consortium, of the Leiden-Amsterdam Center of Drug Research (LACDR) at the Vrije Universiteit (Amsterdam), the Institute of Molecules and Materials (IMM) at the Radboud Universiteit (Nijmegen) and Organon BioSciences (Oss) has been created to develop innovative and integrative strategies for metabolite production, metabolic stability assessment and metabolite profiling. The new strategies are based on integration of combinatorial biochemistry and biocatalysis with Cytochromes P450, high-information content LC-MS, high-efficient LC-NMR and structure identification software routines.
Monday, November 19, 2007
European User Meeting on Transnational Access: Research Infrastructure Centre
- Wageningen NMR Centre and Bioqualys BV are delighted to invite to for the first User Meeting for the EU supported clients of the Transitional Access: Research Infrastructure Centre (RITA) project. The meeting will be on November 29 and 30, 2007 in Hotel, Congres en partycentrum De Wageningse Berg in Wageningen, the Netherlands.
The mini-symposium on Friday afternoon includes these presentations:
- Prof. Dr. John C. Lindon, Imperial College London: NMR computational chemistry, multivariate analysis and their application to medicine
- Dr. Peter Rinke, Technical Manager at SGF/IRMA: Quality assessment of fruit juices using NMR
- Dr. Jacques Vervoort, Wageningen University: NMR and MS - The Dream Team
- Dr. Hartmunt Schaefer, Bruker BioSpin: New tools for NMR based metabonomics
- Dr. Maarten Honing, Organon, Medicinal Chemistry: LC-MS-NMR: the ultimate tool or identifying unknowns?
Labels:
200711,
metabolomics,
NMR,
symposium,
WUR
Subscribe to:
Posts (Atom)